GlaxoSmithKline - Consumer Healthcare Portfolio - Ownership and Business Overview

Life ScienceCompany

GlaxoSmithKline - Consumer Healthcare Portfolio Ownership

Who owns GlaxoSmithKline - Consumer Healthcare Portfolio?

GlaxoSmithKline - Consumer Healthcare Portfolio is owned by Crown Laboratories and Hildred Capital Partners. It was acquired on November 30, 2018.

Is GlaxoSmithKline - Consumer Healthcare Portfolio PE-backed?

Yes. GlaxoSmithKline - Consumer Healthcare Portfolio is owned by private equity investors Crown Laboratories and Hildred Capital Partners.

GlaxoSmithKline - Consumer Healthcare Portfolio Business Overview

Where is GlaxoSmithKline - Consumer Healthcare Portfolio headquartered?

GlaxoSmithKline - Consumer Healthcare Portfolio is headquartered in Brentford, United Kingdom.

What sector is GlaxoSmithKline - Consumer Healthcare Portfolio in?

GlaxoSmithKline - Consumer Healthcare Portfolio is a life science company.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

GlaxoSmithKline plc - Consumer Healthcare Portfolio

Brentford, TW8 9GS
United Kingdom,

GlaxoSmithKline plc - Consumer Healthcare Portfolio has long been regarded as high quality, safe and effective, maintaining a quality image and loyal base of consumers. OTC medications allow practitioners and their patients the ability to access therapeutic products while reducing the burden of prescription drug costs on the healthcare system. The products expand Crown Laboratories’ consumer portfolio by adding #1 in category brands that treat multiple conditions. The acquired portfolio includes PanOxyl®: #1 Dermatologist recommended daily acne wash Sarna®: #1 Dermatology recommended anti-itch lotion Zeasorb®: #1 Dermatologist recommended anti-fungal and prevention product Desenex®: Anti-fungal powder for athlete’s foot Mineral Ice®: Leading pain-relieving gel.


 Subscribe to unlock this and 207,673
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for GlaxoSmithKline - Consumer Healthcare Portfolio

Life Science Companies , United Kingdom Companies